Home >> Industry News >> FDA authorizes Fujirebio test for Alzheimer disease

FDA authorizes Fujirebio test for Alzheimer disease

image_pdfCreate PDF

The assay is analyzed on Fujirebio’s fully automated Lumipulse G1200 system, which is available to clinical laboratories nationwide.

CAP TODAY
X